Expensify (EXFY) Competitors $1.92 +0.01 (+0.52%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$1.94 +0.02 (+0.99%) As of 09/5/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXFY vs. ECX, WEAV, DOMO, OSPN, DH, LZMH, CCSI, CANG, BLZE, and ATGLShould you be buying Expensify stock or one of its competitors? The main competitors of Expensify include ECARX (ECX), Weave Communications (WEAV), Domo (DOMO), Onespan (OSPN), Definitive Healthcare (DH), LZ Technology (LZMH), Consensus Cloud Solutions (CCSI), Cango (CANG), Backblaze (BLZE), and Alpha Technology Group (ATGL). These companies are all part of the "computer software" industry. Expensify vs. Its Competitors ECARX Weave Communications Domo Onespan Definitive Healthcare LZ Technology Consensus Cloud Solutions Cango Backblaze Alpha Technology Group ECARX (NASDAQ:ECX) and Expensify (NASDAQ:EXFY) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk. Which has stronger valuation and earnings, ECX or EXFY? Expensify has lower revenue, but higher earnings than ECARX. Expensify is trading at a lower price-to-earnings ratio than ECARX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioECARX$761.90M0.75-$127.73M-$0.36-4.28Expensify$139.24M1.11-$10.06M-$0.16-12.00 Which has more risk and volatility, ECX or EXFY? ECARX has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Comparatively, Expensify has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Do analysts prefer ECX or EXFY? ECARX currently has a consensus price target of $3.20, indicating a potential upside of 107.79%. Expensify has a consensus price target of $4.00, indicating a potential upside of 108.33%. Given Expensify's higher possible upside, analysts plainly believe Expensify is more favorable than ECARX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ECARX 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Expensify 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals believe in ECX or EXFY? 68.4% of Expensify shares are owned by institutional investors. 20.0% of ECARX shares are owned by company insiders. Comparatively, 12.3% of Expensify shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is ECX or EXFY more profitable? Expensify has a net margin of -10.72% compared to ECARX's net margin of -15.40%. ECARX's return on equity of 0.00% beat Expensify's return on equity.Company Net Margins Return on Equity Return on Assets ECARX-15.40% N/A -22.84% Expensify -10.72%-12.02%-8.52% Does the media favor ECX or EXFY? In the previous week, Expensify had 1 more articles in the media than ECARX. MarketBeat recorded 5 mentions for Expensify and 4 mentions for ECARX. ECARX's average media sentiment score of 0.92 beat Expensify's score of -0.29 indicating that ECARX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ECARX 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Expensify 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryExpensify beats ECARX on 10 of the 16 factors compared between the two stocks. Get Expensify News Delivered to You Automatically Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXFY vs. The Competition Export to ExcelMetricExpensifyFinancial Transaction Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$154.65M$33.60B$6.67B$9.92BDividend YieldN/A2.15%2.74%4.52%P/E Ratio-12.0041.0827.1526.11Price / Sales1.1112.511,098.94189.73Price / CashN/A18.5726.9459.28Price / Book1.167.146.896.09Net Income-$10.06M$1.11B$199.16M$266.51M7 Day Performance-2.04%-1.86%-0.06%0.45%1 Month Performance-1.03%4.64%9.24%5.05%1 Year Performance-14.29%28.84%46.61%26.03% Expensify Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXFYExpensify2.7241 of 5 stars$1.92+0.5%$4.00+108.3%-14.3%$154.65M$139.24M-12.00140ECXECARX2.2579 of 5 stars$1.62+2.5%$3.20+97.5%-10.5%$600.58M$761.90M-4.501,918WEAVWeave Communications2.9334 of 5 stars$7.78+1.1%$15.10+94.2%-25.4%$599.34M$204.31M-19.44890News CoveragePositive NewsDOMODomo4.4522 of 5 stars$14.68-4.2%$17.00+15.8%+109.8%$590.65M$317.04M-7.57920OSPNOnespan4.8691 of 5 stars$15.13+1.9%$19.67+30.0%+1.5%$579.66M$243.18M10.02790News CoveragePositive NewsAnalyst UpgradeDHDefinitive Healthcare1.8103 of 5 stars$4.03+0.5%$4.73+17.5%-7.0%$576.86M$252.20M-1.52970Positive NewsLZMHLZ TechnologyN/A$3.65+0.6%N/AN/A$547.50MN/A0.0067CCSIConsensus Cloud Solutions1.833 of 5 stars$26.57-0.5%$27.40+3.1%+18.1%$504.22M$350.38M6.40460Positive NewsCANGCango2.2922 of 5 stars$4.77-2.6%$8.00+67.9%+203.7%$495.04M$110.21M-238.132,350News CoverageAnalyst ForecastBLZEBackblaze2.8039 of 5 stars$8.35-0.6%$10.07+20.6%+51.3%$471.77M$127.63M-9.38270News CoveragePositive NewsATGLAlpha Technology GroupN/A$30.70+3.7%N/A+1,848.8%$468.56M$1.59M0.0023News CoverageGap Down Related Companies and Tools Related Companies ECARX Competitors Weave Communications Competitors Domo Competitors Onespan Competitors Definitive Healthcare Competitors LZ Technology Competitors Consensus Cloud Solutions Competitors Cango Competitors Backblaze Competitors Alpha Technology Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXFY) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Expensify, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Expensify With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
